Toggle Main Menu Toggle Search

Open Access padlockePrints

A very early rehabilitation trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial

Lookup NU author(s): Emerita Professor Helen Rodgers

Downloads


Licence

This is the final published version of an article that has been published in its final definitive form by NIHR Journals Library, 2017.

For re-use rights please refer to the publisher's terms and conditions.


Abstract

© Queen’s Printer and Controller of HMSO 2017. Background: Mobilising patients early after stroke [early mobilisation (EM)] is thought to contribute to the beneficial effects of stroke unit care but it is poorly defined and lacks direct evidence of benefit. Objectives: We assessed the effectiveness of frequent higher dose very early mobilisation (VEM) after stroke. Design: We conducted a parallel-group, single-blind, prospective randomised controlled trial with blinded end-point assessment using a web-based computer-generated stratified randomisation. Setting: The trial took place in 56 acute stroke units in five countries. Participants: We included adult patients with a first or recurrent stroke who met physiological inclusion criteria. Interventions: Patients received either usual stroke unit care (UC) or UC plus VEM commencing within 24 hours of stroke. Main outcome measures: The primary outcome was good recovery [modified Rankin scale (mRS) score of 0-2] 3 months after stroke. Secondary outcomes at 3 months were the mRS, time to achieve walking 50 m, serious adverse events, quality of life (QoL) and costs at 12 months. Tertiary outcomes included a dose-response analysis. Data sources: Patients, outcome assessors and investigators involved in the trial were blinded to treatment allocation. Results: We recruited 2104 (UK, n = 610; Australasia, n = 1494) patients: 1054 allocated to VEM and 1050 to UC. Intervention protocol targets were achieved. Compared with UC, VEM patients mobilised 4.8 hours [95% confidence interval (CI) 4.1 to 5.7 hours; p < 0.0001] earlier, with an additional three (95% CI 3.0 to 3.5; p < 0.0001) mobilisation sessions per day. Fewer patients in the VEM group (n = 480, 46%) had a favourable outcome than in the UC group (n = 525, 50%) (adjusted odds ratio 0.73, 95% CI 0.59 to 0.90; p = 0.004). Results were consistent between Australasian and UK settings. There were no statistically significant differences in secondary outcomes at 3 months and QoL at 12 months. Dose-response analysis found a consistent pattern of an improved odds of efficacy and safety outcomes in association with increased daily frequency of out-of-bed sessions but a reduced odds with an increased amount of mobilisation (minutes per day). Limitations: UC clinicians started mobilisation earlier each year altering the context of the trial. Other potential confounding factors included staff patient interaction. Conclusions: Patients in the VEM group were mobilised earlier and with a higher dose of therapy than those in the UC group, which was already early. This VEM protocol was associated with reduced odds of favourable outcome at 3 months cautioning against very early high-dose mobilisation. At 12 months, health-related QoL was similar regardless of group. Shorter, more frequent mobilisation early after stroke may be associated with a more favourable outcome.


Publication metadata

Author(s): Langhorne P, Wu O, Rodgers H, Ashburn A, Bernhardt J

Publication type: Article

Publication status: Published

Journal: Health Technology Assessment

Year: 2017

Volume: 21

Issue: 54

Pages: 1-119

Print publication date: 01/10/2017

Online publication date: 01/10/2017

Acceptance date: 02/04/2016

Date deposited: 21/12/2017

ISSN (print): 1366-5278

ISSN (electronic): 2046-4924

Publisher: NIHR Journals Library

URL: https://doi.org/10.3310/hta21540

DOI: 10.3310/hta21540


Altmetrics

Altmetrics provided by Altmetric


Actions

Find at Newcastle University icon    Link to this publication


Share